What Is Going On with This Power Grid Stock? Shares of PFISTERER (WKN: PFSE21 | ISIN: DE000PFSE212 | Ticker: PFSE) closed ...

Moderna developed the vaccine with Merck and tested it together with Keytruda, a common immunotherapy treatment for melanoma.

Moderna and Merck said an experimental cancer vaccine paired with Keytruda helped prevent the recurrence of melanoma in a Phase 3 trial. In 2019, a friend noticed a suspicious mole on Angela Evatt's ...

U.S. Treasury Secretary Scott Bessent said the U.S. likely won't need to restart large-scale combat with Iran.

Moderna & Merck said a late-stage trial of a personalized cancer treatment based on the mRNA technology behind Covid-19 vaccines met its goals in treating melanoma.

Moderna has released new results showing that combining its experimental cancer vaccine with standard treatment may help ...

Moderna Chairman Noubar Afeyan says the trial results remind him of when his company developed its Covid-19 vaccine.

Even with a modest 25% success rate for the company's current phase 2 programs, Moderna should be able to launch enough new ...

In light of recent wins for mRNA vaccine makers, UCSC RNA Center Co-Director Jeremy Sanford describes the versatility of the ...

If ongoing studies in other cancers produce similar results, the technology could influence far more than cancer care itself.

Technological advances inevitably generate backlash — witness the resistance to covid vaccines and the revolt against data centers. But they also produce life-improving feats that are too miraculous ...

Merck and Moderna's mRNA cancer vaccine hit its Phase 3 trial endpoint, showing improved recurrence-free survival in melanoma ...